Note: Cover -- Title -- Copyright -- Contents -- Forevvord -- Organising and Programme Committee Members -- Opening Session Papers -- Opening Address by Dr. K. Thambimuthu, Chairman, lEA Greenhouse Gas R& -- D Programme -- Opening Speech by the Hon. W. Entsch, Parliamentary Secretary to the Minister for Industry, Science & -- Resources -- Plenary Sessions Papers -- The Science of Climate Change: An Update -- Sustaining Sustainability: Technology -- Energy in the 21 st Century: The Role of GHG Control Technologies -- Climate Policy, CO[sub(2)] Storage and Public Perception -- Harnessing Technology to Achieve Sustainability -- The Role of Carbon Management Technologies in Addressing Atmospheric Stabilization of Greenhouse Gases -- The Role of Carbon Sequestration in the Longer Term Energy Future -- A Policy Framework for Sustainable Energy -- Technology for Sustainable Energy - A CSIRO Perspective -- Capture of CO[sub(2)] -- International Test Centre for Carbon Dioxide (C0[sub(2)]) Capture -- Leading Options for the Capture of CO[sub(2)] at Power Stations -- Natural Gas Fired Power Cycles with Integrated CO[sub(2)] Capture -- Existing Coal Power Plant Retrofit CO[sub(2)] Control Options Analysis -- Simulation of CO[sub(2)] Capture for an Existing Pulverized Coal Power Plant -- Gas Treating Using Membrane Gas/Liquid Contactors -- The Kvaerner Membrane Contactor: Lessons from a Case Study in How to Reduce Capture Costs -- Study on Hybrid Process Combining Gas Membrane and PSA for Carbon Dioxide Purification -- Economical Carbon Dioxide Recovery for Sequestration from a Solid Oxide Fuel Cell Power Plant -- Development and Application of Flue Gas Carbon Dioxide Recovery Technology -- Economics and Cost Studies of Energy Efficient Solvents and Cogeneration Process for CO2Separation From Flue Gas Streams. , High Temperature CO[sub(2)] Removal Technique Using Novel Solid Chemical Absorbent -- Capture of CO[sub(2)] Using Water Scrubbing -- Study on CO[sub(2)] Removal Technology from Flue Gas of Thermal Power Plant by Combined System With Pressure Swing Adsorption and Super Cold Separator -- Economical Assessment of Natural Gas Fired Combined Cycle Power Plant With CO[sub(2)] Capture and Sequestration -- Economic Evaluation of Capture and Sequestration of CO[sub(2)] from Australian Black Coal-Fired Power Stations -- A Study on the Capture of Carbon Dioxide from a Large Refinery Power Station Boiler by Conversion to Oxyfuel Operation -- Simulation of Coal Combustion in a High CO[sub(2)] and O[sub(2)] Environment -- Update of New Power Plant CO[sub(2)] Control Options Analysis -- Carbon Dioxide Reduced Processes -- Possibility of Using Iron Oxide as an Oxygen Carrier for Combustion of Methane with Removal of CO[sub(2)]-Application of Chemical-Looping Combustion -- An Investigation of Solvent Stability in Amine Based Systems Used to Capture CO[sub(2)] -- CO[sub(2)]-MEA Absorption in Packed Columns: Comprehensive Experimental Data and Modelling Results -- Oxygen Enhanced Combustion Strategies for CO[sub(2)] Capture Using Natural Gas as a Fuel -- Comparisons of CO[sub(2)]-Reducing Alternatives for Heat and Power Generation: CO[sub(2)]-Capture and Fuel Shift to Biomass -- Effect of Super Absorbent Polymer (SAP) on the Water Characteristic Curves of a Sandy Layer for Arid Land Forestation -- Geological Storage of CO[sub(2)] -- CO[sub(2)] Sequestration in Oil Reservoirs - A Monitoring and Research Opportunity -- The CO[sub(2)] Capture Joint Industry Project -- The GEODISC Program: Research into Geological Sequestration of CO[sub(2)] in Australia -- The GESTCO Project: Assessing European Potential for Geological Storage of CO[sub(2)] from Fossil Fuel Combustion. , Options for Establishing a North Sea Geological Storage Hub -- Progress in Understanding the Potential Role of CO[sub(2)] Storage -- Sequestration of CO[sub(2)] in Depleted Oil & -- Gas Fields: Global Capacity, Costs and Barriers -- The Transform of the Geological Space into the CO[sub(2)]-Phase Space: A Step Toward the Identification of CO[sub(2)] Storage Capacity of Sedimentary Basins -- Reservoir Engineering Issues in the Geological Disposal of Carbon Dioxide -- Underground Sequestration of Carbon Dioxide in Tectonically Active Area -- Comparison of Three Options for Geologic Sequestration of CO[sub(2)] - A Case Study for California -- Monitoring of CO[sub(2)] Sequestration Using Integrated Geophysical and Reservoir Data -- Geological CO[sub(2)] Disposal: Understanding the Long Term Fate of CO[sub(2)] in Natural Occuring Accumulations -- Elmo Dome and St.Johns Natural CO[sub(2)] Deposits: Analogs for Geologic Sequestration -- CO[sub(2)] Storage in Solid Form: A Study of Direct Mineral Carbonation -- From Suitability to Ultimate Capacity: A Roadmap for Assessing Sedimentary Basinsand Selecting Sites for CO[sub(2)] Storage in Geological Media -- Applications of Neutral Barrier Technology for Greenhouse Gas Containment -- The GEO-SEQ Project -- A New CO[sub(2)] Disposal Process Using Artificial Rock Weathering -- The Utsira Sand, Central North Sea - An Assessment of its Potential for Regional CO[sub(2)] Storage -- How Will Reservoir and Caprock React with Injected CO[sub(2)] at Sieipner? Preliminary Evidencefrom Experimental Investigations -- Prediction of Migration of CO[sub(2)] Injected into an Underground Depository: Reservoir Geology and Migration Modelling in the Sieipner Case (North Sea) -- Geophysical Methods for Monitoring Marine Aquifer CO[sub(2)] Storage - Sieipner Experiences. , Prediction of CO[sub(2)] Distribution Pattern Improved by Geology and Reservoir Simulation and Verified by Time Lapse Seismic -- Prediction of Migration of CO[sub(2)] After Injected in a Saline Aquifer: Reservoir History Matching of a 40 Seismic Image with a Compositional Gas/Water Model -- Regional and Site-Specific Hydrogeologic Constraints on CO2 Sequestration in the Midwestern United States Saline Formations -- Experimental Evaluation of Chemical Sequestration of Carbon Dioxide in Deep Saline Formations -- Ocean Storage of CO[sub(2)] -- Update on the International Experiment on CO[sub(2)] Ocean Sequestration -- Public Outreach Effort for CO[sub(2)] Ocean Sequestration Experiment -- Application of a Double Plume Model to Compute Near Field Mixing for the International Field Experiment on CO[sub(2)] Ocean Sequestration -- A Numerical Prediction on Plume Structure of Liquid CO[sub(2)] in the Ocean - A Near Field Model -- Simulation Experiment of CO[sub(2)] Storage at 3600m Deep Ocean Floor -- A Generic Modelling System for Ocean Storage of CO[sub(2)] -- Stability of CO[sub(2)] in Different Phases Related to Ocean Storage -- Assessing Change in CO[sub(2)] Chemistry in Seawater in a Proposed International CO[sub(2)] Ocean Sequestration Experiment -- Ocean Nourishment in the Humbolt Current -- Enhancement of Oceanic Uptake of Anthropogenic CO[sub(2)] by Macro-nutrient Fertilisation -- Ocean Dispersion of CO[sub(2)] from a Moving Ship Source -- A Benign Form of CO[sub(2)] Sequestering in the Ocean -- Ocean CO[sub(2)] Sequestration Efficiency from 3-D Ocean Model Comparison -- Numerical Simulation of Dilution Process in CO[sub(2)] Ocean Sequestration -- Formation of Liquid CO[sub(2)] Droplets and Jets with Deformation and Growth of Hydrate Film -- CO[sub(2)] Ocean Sequestration Project in RITE. , Two Types of Strength Abnormality of CO[sub(2)] Hydrate Membrane -- Combining Ocean Sequestration of CO[sub(2)] and OTEC -- A Win-Win Solution? -- Oceanographic Criteria for Selecting Future Sites for CO[sub(2)] Sequestration -- Responses of Marine Biological Communities to Different Concentration of CO[sub(2)] in a Mesocosm Experiment -- Previews of CO[sub(2)] Injection System for CO[sub(2)] Ocean Sequestration -- Replacing Methane with CO[sub(2)] in Clathrate Hydrate: Observations Using Raman Spectroscopy -- Storage of CO[sub(2)] with Enhanced Hydrocarbon Recovery -- Site Ranking for CO[sub(2)]-Enhanced Coalbed Methane Demonstration Pilots -- Modelling of Carbon Dioxide Sequestration in Coal beds: A Numerical Challenge -- Economics of Flue Gas Injection and CO[sub(2)] Sequestration in Coalbed Methane Reservoirs -- CO[sub(2)]-Storage / ECBM Production Scenarios for the Campine Basin (Belgium) -- CO[sub(2)]-Sequestration in The Netherlands: Inventory of the Potential for the Combination of Subsurface Carbon Dioxide Disposal with Enhanced Coalbed Methane Production -- CO[sub(2)]-Sequestration in The Netherlands. CO[sub(2)] Injection and CH[sub(4)] Production as Relatedto the Dutch Situation: Laboratory Experiments and Field Simulations -- Transporting Carbon Dioxide Recovered from Fossil-Energy Cycles -- Unminable Coals in Eastern U.S. Basins: Potential Reservoirs for Sequestering Carbon Dioxide -- Subsurface Biogeochemical Carbon Recycling: CO[sub(2)]-EGR with Microbial Methanogenesis in Geochemically Sealed Aquifers -- CO[sub(2)]-Sequestration in the Netherlands: Feasibility and Techno-Economic Evaluation of Coalbed Methane Production Combined with CO[sub(2)]-Storage - Preliminary Results -- CO[sub(2)] Sequestration. in an Unminable Coalbed - San Juan Basin, Colorado, USA. , Geological Sequestration of CO[sub(2)] in Coal Seams: Reservoir Mechanisms Field Performance and Economics.

Note: Cover -- Contents -- List of Contributors -- Preface -- Introduction -- Chemopreventive Compounds in the Diet -- Abstract -- Vitamin C -- Food Sources -- Function -- Deficiency -- Disease Prevention -- Cardiovascular Diseases -- Cancer -- Cataracts -- Safety -- Vitamin E -- Food Sources -- Function -- alpha-Tocopherol -- gama-Tocopherol -- Deficiency -- Disease Prevention -- Cardiovascular Diseases -- Cancer -- Cataracts -- Immune Function -- Safety -- Copper -- Food Sources -- Function -- Nutrient-Nutrient Interactions -- Deficiency -- Individuals at Risk of Deficiency -- Disease Prevention -- Cardiovascular Diseases -- Osteoporosis -- Immune Function -- Safety -- Selenium -- Food Sources -- Function -- Nutrient-Nutrient Interactions -- Deficiency -- Individuals at Risk of Deficiency -- Disease Prevention -- Cardiovascular Diseases -- Cancer -- Immune Function -- Viral Infection -- Safety -- Zinc -- Food Sources -- Function -- Nutrient-Nutrient Interactions -- Deficiency -- Disease Prevention -- Growth and Development -- Immune Function -- Pregnancy Complications -- Age-Related Macular Degeneration -- Safety -- Carotenoids: alpha-Carotene, beta-Carotene, beta-Cryptoxanthin, Lycopene, Lutein and Zeaxanthin -- Food Sources -- Function -- Deficiency -- Disease Prevention -- Cardiovascular Diseases -- Age-Related Macular Degeneration -- Cataracts -- Cancer -- Bioavailability of Carotenoids -- Safety -- Interactions among Drugs and Carotenoids -- Polyphenols and Flavonoids -- Food Sources -- Function -- Disease Prevention -- Antioxidant Properties and Enzyme Inhibition -- Anti-Inflammatory Activity -- Vascular Activity -- Coronary Heart Disease -- Cytotoxic Antitumor Activity -- Estrogenic Activity -- Other Biological Activities -- Safety -- alpha-Lipoic Acid -- Food Sources -- Function -- Deficiency -- Disease Prevention -- Diabetes mellitus. , Safety -- Acknowledgement -- References -- Biochemistry -- Vitamin C, Vitamin E and Flavonoids -- Abstract -- Reactive Oxygen Species and the Eye -- Ascorbic Acid (Vitamin C) -- Tocopherols (Vitamin E) -- Flavonoids -- Synergistic Effects -- Conclusion -- References -- Macular Carotenoids: Lutein and Zeaxanthin -- Abstract -- Structure and Biosynthesis -- Occurrence in Food -- Absorption, Distribution and Metabolism -- The Macular Pigment -- Oxidative Stress -- Photooxidative Stress -- Carotenoids as Antioxidants -- Carotenoids as Blue Light Filters -- Conclusion -- References -- Selenium, Selenoproteins and Vision -- Abstract -- Unspecific Selenium Effects versus Enzymatic Selenium Catalysis -- Selenoproteins of the Eye -- Glutathione Peroxidases and Experimental Cataracts -- Animal Experiments versus Clinical Experience -- Conclusions -- References -- Clinics -- Nutritional Supplementation to Prevent Cataract Formation -- Abstract -- Cataract Development -- Therapeutics -- Vitamin C -- Vitamin E -- Carotenoids -- Epidemiological Studies -- Clinical Interventional Studies -- 'Linxian' Studies -- The AREDS Trial -- The REACT Study -- The PHS Studies -- The ATBC Study -- The VECAT Study -- Conclusion -- References -- Nutrition and Retina -- Abstract -- Age-Related Macular Degeneration -- Nutrition and Pathomechanisms in AMD -- Oxidative Stress Theory -- Choroidal Circulation Theory -- Bruch's Membrane Theory -- Dietary Components with a Possible Role in Retinal Degeneration -- Antioxidants -- Vitamin E -- Vitamin C -- Carotenoids -- beta-Carotene -- Lutein and Zeaxanthin -- Cofactors of Antioxidant Enzymes -- Folic Acid -- Nutritional Risk Factors -- Dietary Fat Intake -- Smoking -- Alcohol -- The Age-Related Eye Disease Study -- Conclusion -- Diabetic Retinopathy/Maculopathy -- Conclusion -- References -- Author Index -- Subject Index -- A -- B -- C. , D -- F -- G -- I -- K -- L -- M -- N -- O -- P -- R -- S -- T -- V -- Z.

Note: THE ELEPHANT'S FOOT -- CONTENTS -- INTRODUCTION -- ACKNOWLEDGMENTS -- Part I The Context of Elephant Foot Care -- 1 AN OVERVIEW OF FOOT CONDITIONS IN ASIAN AND AFRICAN ELEPHANTS -- 2 ANATOMY OF THE ELEPHANT FOOT -- 3 THE ROLE OF NUTRITION AND ITS POSSIBLE IMPACT ON ELEPHANT FOOT CARE -- 4 RECORD KEEPING AS AN AID TO FOOT CARE IN THE ASIAN ELEPHANT -- Part II Approaches to Routine Foot Care -- 5 FOOT CARE FOR CAPTIVE ELEPHANTS -- 6 CAPTIVE ELEPHANT FOOT CARE: NATURAL- HABITAT HUSBANDRY TECHNIQUES -- 7 FOOT CARE AT THE INDIANAPOLIS ZOO: A COMPREHENSIVE APPROACH -- 8 ELEPHANT FOOT CARE UNDER PROBLEMS AND SOLUTIONS THE VOLUNTARY-CONTACT SYSTEM: -- 9 A HISTORY OF ELEPHANT FOOT CARE AT THE MILWAUKEE COUNTY ZOO -- 10 ELEPHANT HUSBANDRY AND FOOT CARE AT THE SCHONBRUNNER TIERGARTEN, VIENNA -- 11 PREVENTIVE FOOT CARE FOR AN ASIAN ELEPHANT AT MESKER PARK ZOO AND BOTANIC GARDEN -- PART III Common Elephant Foot Conditions and Their Treatment -- 12 HISTORICAL LESSONS FOR THE TREATMENT OF FOOT DISEASES IN CAPTIVE ASIAN ELEPHANTS -- 13 SPLIT NAILS, ABSCESSES, AND CUTICULAR FLUID POCKETS -- 14 OUCH, DO THAT AGAIN! TREATMENT OF CHRONIC NAIL INFECTIONS IN AN ASIAN BULL ELEPHANT USING PROTECTED CONTACT -- 15 PROCEDURE FOR NAIL RECONSTRUCTION AND TREATMENT FOR AN ASIAN ELEPHANT (ELEPHAS MAXIMUS) -- 16 OCCURRENCE AND TREATMENT OF NAILFOOT ABSCESSES, NAIL CRACKS, AND SOLE ABSCESSES IN CAPTIVE ELEPHANTS -- 17 SIRI'S DILEMMA: MANAGEMENT OF A CHRONIC FOOT PROBLEM -- 18 MAKING A PROTECTIVE BOOT FOR AN ASIAN ELEPHANT -- 19 TREATMENT OF AN ABSCESSED FOOT PAD OF AN AFRICAN ELEPHANT (LOXODONTA AF'RICANA) USING A SANDAL AND TOPICALLY APPLIED CHITOSAN -- 20 THE USE OF SONOGRAPHY IN THE FOLLOW-UP CARE OF A FOOT ABSCESS IN A FEMALE ASIAN ELEPHANT (ELEPHAS MAXIMUS) -- 21 TREATMENT OF OSTEOMYELITIS IN ELEPHANT FEET -- PART IV Surgical Intervention for Elephant Foot Disease. , 22 THE MEDICAL AND SURGICAL MANAGEMENT OF FOOT ABSCESSES IN CAPTIVE ASIATIC ELEPHANTS: CASE STUDIES -- 23 PREOPERATIVE CONDITIONING AND POSTOPERATIVE TREATMENTS OF A PROTECTED-CONTACT BULL ELEPHANT -- 24 SURGICAL MANAGEMENT OF A CHRONIC INFECTION INVOLVING THE PHALANGE OF AN ASIAN ELEPHANT (ELEPHAS MAXIMUS) -- 25 SURGICAL MANAGEMENT OF PHALANGEAL OSTEOMYELITIS IN A FEMALE ASIAN ELEPHANT (ELEPHAS MAXIMUS) -- PART V Antibiotic and Anti-inflammatory Dosages for Elephants -- 26 DETERMINING DOSAGES FOR ANTIBIOTIC AND ANTI-INFLAMMATORY AGENTS -- PART VI Conclusions and Recommendations -- 27 ELEPHANT FOOT CARE: CONCLUDING REMARKS -- APPENDIX I ELEPHANT MANAGEMENT GUIDELINES (MARCH 1997) -- APPENDIX II RESULTS OF A SURVEY OF ELEPHANT FOOT CONDITION AND CARE IN NORTH AMERICA -- GLOSSARY -- CONTRIBUTORS -- INDEX.

Note: Rabbits -- CONTENTS -- Preface -- 1 Husbandry -- 2 Nutrition -- 3 The Clinical Examination -- 4 The Skin -- 5 The Reproductive System -- 6 The Neonatal Rabbit -- 7 The Urinary System -- 8 The Respiratory System -- 9 The Digestive System -- 10 The Musculoskeletal System -- 11 The Teeth -- 12 The Head and Neck -- 13 Neurological and Neuromuscular Disorders -- 14 Important Viral Diseases -- 15 Behaviour -- 16 Anaesthesia and Surgery -- 17 Drugs and Treatments -- 18 Zoonotic Aspects -- References and further reading -- Index.

Note: NITRITE CURING OF MEAT -- CONTENTS -- 1 . INTRODUCTION -- 2 . HISTORY OF THE CURING PROCESS -- 3 . THE COLOR OF MEAT -- 4 . OXIDATIVE STABILITY OF MEAT LIPIDS -- 5 . FLAVOR OF MEAT -- 6 . MEAT MICROBIOLOGY -- 7 . THE FATE OF NITRITE -- 8 . POTENTIAL HEALTH CONCERNS ABOUT NITRITE -- 9 . POSSIBLE SUBSTITUTES FOR NITRITE -- GLOSSARY -- INDEX.

Note: Industrial inorganic Chemistry -- Contents -- 1 Primary Inorganic Materials -- 1.1 Water -- 1.1.1 Economic Importance -- 1.1.2 Production of Potable Water -- 1.1.2.1 Break-Point Chlorination and Ozonization -- 1.1.2.2 Flocculation and Sedimentation -- 1.1.2.3 Filtration -- 1.1.2.4 Removal of Dissolved Inorganic Impurities -- 1.1.2.5 Activated Charcoal Treatment -- 1.1.2.6 Safety Chlorination -- 1.1.2.7 Production of Soft or Deionized Water -- 1.1.3 Production of Freshwater from Seawater and Brackish Water -- 1.1.3.1 Production by Multistage Flash Evaporation -- 1.1.3.2 Production using Reverse Osmosis -- References for Chapter 1.1 : Water -- 1.2 Hydrogen -- 1.2.1 Economic Importance -- 1.2.2 Hydrogen Manufacture -- 1.2.2.1 Petrochemical Processes and Coal Gasification -- 1.2.2.2 Electrolysis of Water -- 1.2.2.3 Other Manufacturing Processes for Hydrogen -- 1.2.2.4 Production of Hydrogen as a Byproduct -- 1.2.3 Hydrogen Applications -- References for Chapter 1.2: Hydrogen -- 1.3 Hydrogen Peroxide and Inorganic Peroxo Compounds -- 1.3.1 Economic Importance -- 1.3.1.1 Hydrogen Peroxide -- 1.3.1.2 Sodium Perborate and Sodium Carbonate Perhydrate -- 1.3.1.3 Alkali Peroxodisulfates and Sodium Peroxide -- 1.3.2 Production -- 1.3.2.1 Hydrogen Peroxide -- 1.3.2.2 Sodium Perborate -- 1.3.2.3 Sodium Carbonate Perhydrate -- 1.3.2.4 Alkali Peroxodisulfate -- 1.3.2.5 Sodium Peroxide -- 1.3.3 Applications -- 1.3.3.1 Hydrogen Peroxide, Sodium Perborate and Sodium Carbonate Perhydrate -- 1.3.3.2 Alkali Peroxodisulfates and Sodium Peroxide -- References for Chapter 1.3: Hydrogen Peroxide and Inorganic Peroxo Compounds -- 1.4 Nitrogen and Nitrogen Compounds -- 1.4.1 Ammonia -- 1.4.1.1 Economic Importance -- 1.4.1.2 Synthetic Ammonia Manufacture -- 1.4.1.2.1 General Information -- 1.4.1.2.2 Ammonia Synthesis Catalysts -- 1.4.1.2.3 Synthesis Gas Production. , 1.4.1.2.4 Conversion of Synthesis Gas to Ammonia -- 1.4.1.2.5 Integrated Ammonia Synthesis Plants -- 1.4.1.3 Ammonia Applications -- References for Chapter 1.4: Nitrogen and Nitrogen Compounds -- 1.4.2 Hydrazine -- 1.4.2.1 Economic Importance -- 1.4.2.2 Manufacture of Hydrazine -- 1.4.2.2.1 Raschig Process -- 1.4.2.2.2 Urea Process -- 1.4.2.2.3 Bayer Process -- 1.4.2.2.4 H2O2 Process -- 1.4.2.3 Applications of Hydrazine -- References for Chapter 1.4.2: Hydrazine -- 1.4.3 Hydroxylamine -- 1.4.3.1 Economic Importance and Applications -- 1.4.3.2 Manufacture -- 1.4.3.2.1 Raschig Process -- 1.4.3.2.2 Nitrogen(II) Oxide Reduction Process -- 1.4.3.2.3 Nitrate Reduction Process (DSM/HPO-Stamicarbon) -- References for Chapter 1.4.3: Hydroxylamine -- 1.4.4 Nitric Acid -- 1.4.4.1 Economic Importance -- 1.4.4.2 Manufacture -- 1.4.4.2.1 Fundamentals of Nitric Acid Manufacture -- 1.4.4.2.2 Plant Types -- 1.4.4.2.3 Process Description -- 1.4.4.2.4 Manufacture of Highly Concentrated Nitric Acid -- 1.4.4.2.5 Tail Gases from Nitric Acid Manufacture -- 1.4.4.3 Nitric Acid Applications -- References for Chapter 1.4.4: Nitric Acid -- 1.5 Phosphorus and its Compounds -- 1.5.1 Phosphorus and Inorganic Phosphorus Compounds -- 1.5.1.1 Raw Materials -- 1.5.1.2 Products -- 1.5.1.2.1 Phosphoric Acid -- 1.5.1.2.2 Phosphoric Acid Salts -- 1.5.1.2.3 Phosphorus -- 1.5.1.2.4 Products Manufactures from Phosphorus -- References for Chapter 1.5.1 : Phosphorus and Inorganic Phosphorus Compounds -- 1.5.2 Organophosphorus Compounds -- 1.5.2.1 Neutral Phosphoric Acid Esters -- 1.5.2.2 Phosphoric Ester Acids -- 1.5.2.3 Dithiophosphoric Ester Acids -- 1.5.2.4 Neutral Esters of Thio- and Dithio-Phosphoric Acids -- 1.5.2.5 Neutral Di- and Triesters of Phosphorous Acid -- 1.5.2.6 Phosphonic Acids -- References for Chapter 1.5.2: Organophosphorus Compounds -- 1.6 Sulfur and Sulfur Compounds. , 1.6.1 Sulfur -- 1.6.1.1 Occurrence -- 1.6.1.2 Economic Importance -- 1.6.1.2.1 Sulfur from Elemental Sulfur Deposits -- 1.6.1.2.2 Sulfur from Hydrogen Sulfide and Sulfur Dioxide -- 1.6.1.2.3 Sulfur from Pyrites -- 1.6.1.3 Economic Importance -- 1.6.1.4 Applications -- 1.6.2 Sulfuric Acid -- 1.6.2.1 Economic Importance -- 1.6.2.2 Starting Materials for Sulfuric Acid Manufacture -- 1.6.2.2.1 Sulfuric Acid from Sulfur Dioxide -- 1.6.2.2.2 Sulfuric Acid from Waste Sulfuric Acid and Metal Sulfates -- 1.6.2.3 Applications of Sulfuric Acid -- 1.6.3 100% Sulfur Dioxide -- 1.6.4 100% Sulfur Trioxide -- 1.6.5 Disulfur Dichloride -- 1.6.6 Sulfur Dichloride -- I .6.7 Thionyl chloride -- 1.6.8 Sulfuryl Chloride -- 1.6.9 Chlorosulfonic Acid -- 1.6.10 Fluorosulfonic Acid -- 1.6.11 Sulfurous Acid Salts -- 1.6.12 Sodium Thiosulfate, Ammonium Thiosulfate -- 1.6.13 Sodium Dithionite and Sodium Hydroxymethanesulfinate -- 1.6.14 Hydrogen Sulfide -- 1.6.15 Sodium Sulfide -- 1.6.16 Sodium Hydrogen Sulfide -- 1.6.17 Carbon Disulfide -- References for Chapter 1.6: Sulfur and Sulfur Compounds -- 1.7 Halogens and Halogen Compounds -- 1.7.1 Fluorine and Fluorine Compounds -- 1.7.1.1 Fluorspar -- 1.7.1.1.1 Fluorspar Extraction -- 1.7.1.1.2 Qualities and Utilization of Fluorspar -- 1.7.1.1.3 Fluorapatite -- 1.7.1.2 Fluorine and Inorganic Fluorides -- 1.7.1.2.1 Fluorine -- 1.7.1.2.2 Hydrogen Fluoride -- 1.7.1.2.3 Aluminum Fluoride -- 1.7.1.2.4 Sodium Aluminum Hexafluoride (Cryolite) -- 1.7.1.2.5 Alkali Fluorides -- 1.7.1.2.6 Hexafluorosilicates -- I .7.1.2.7 Uranium Hexafluoride -- 1.7.1.2.8 Boron Trifluoride and Tetrafluoroboric Acid -- 1.7.1.2.9 Sulfur Hexafluoride -- 1.7.1.3 Organofluoro Compounds by Electrochemical Fluorination -- References for Chapter 1.7.1 : Halogens and Halogen Compounds -- 1.7.2 Chloralkali Electrolysis, Chlorine and Sodium Hydroxide. , 1.7.2.1 Economic Importance -- 1.7.2.2 Starting Materials -- 1.7.2.3 Manufacturing Processes -- 1.7.2.3.1 Mercury Process -- 1.7.2.3.2 Diaphragm Process -- 1.7.2.3.3 Membrane Process -- 1.7.2.3.4 Evaluation of Mercury, Diaphragm and Membrane Processes -- 1.7.2.4 Applications of Chlorine and Sodium Hydroxide -- 1.7.2.4.1 Chlorine -- 1.7.2.4.2 Sodium Hydroxide -- References for Chapter 1.7.2: Chloralkali-Electrolysis -- 1.7.3 Hydrochloric Acid - Hydrogen Chloride -- 1.7.3.1 Manufacture of Hydrogen Chloride -- 1.7.3.2 Economic Importance of Hydrogen Chloride and Hydrochloric Acid -- 1.7.3.3 Electrolysis of Hydrochloric Acid -- 1.7.3.4 Non-Electrolytic Processes for the Manufacture of Chlorine from Hydrogen Chloride -- References for Chapter 1.7.3: Hydrochloric Acid - Hydrogen Chloride -- 1.7.4 Chlorine-Oxygen Compounds -- 1.7.4.1 Economic Importance -- 1.7.4.2 Manufacture of Chlorine-Oxygen Compounds -- 1.7.4.2.1 Hypochlorite -- 1.7.4.2.2 Chlorites -- 1.7.4.2.3 Chlorates -- 1.7.4.2.4 Perchlorates and Perchloric Acid -- 1.7.4.2.5 Chlorine Dioxide -- 1.7.4.3 Applications of Chlorine-Oxygen Compounds -- References for Chapter 1.7.4: Chlorine-Oxygen Compounds -- 1.7.5 Bromine and Bromine Compounds -- 1.7.5.1 Natural Deposits and Economic Importance -- 1.7.5.2 Manufacture of Bromine and Bromine Compounds -- 1.7.5.2.1 Bromine -- 1.7.5.2.2 Hydrogen Bromide -- 1.7.5.2.3 Alkali Bromides, Calcium Bromide, Zinc Bromide -- 1.7.5.2.4 Alkali Bromates -- 1.7.5.3 Applications for Bromine and Bromine Compounds -- References for Chapter 1.7.5: Bromine and Bromine Compounds -- 1.7.6 Iodine and Iodine Compounds -- 1.7.6.1 Economic Importance -- 1.7.6.2 Manufacture of Iodine and Iodine Compounds -- 1.7.6.2.1 Iodine -- 1.7.6.2.2 Hydrogen Iodide -- 1.7.6.2.3 Alkali Iodides -- 1.7.6.2.4 Alkali Iodates -- 1.7.6.3 Applications of Iodine and Iodine Compounds. , References for Chapter 1.7.6: Iodine and Iodine Compounds -- 2 Mineral Fertilizers -- 2.1 Phosphorus-Containing Fertilizers -- 2.1.1 Economic Importance -- 2.1.1.1 General Information -- 2.1.1.2 Importance of Superphosphate -- 2.1.1.3 Importance of Triple Superphosphate -- 2.1.1.4 Importance of Ammonium Phosphates -- 2.1.1.5 Importance of Nitrophosphates -- 2.1.1.6 Importance and Manufacture of Thermal (Sinter, Melt) and Basic Slag (Thomas) Phosphates -- 2.1.2 Manufacture of Phosphorus-Containing Fertilizers -- 2.1.2.1 Superphosphate -- 2.1.2.2 Triple Superphosphate -- 2.1.2.3 Ammonium Phosphates -- 2.1.2.4 Nitrophosphates -- 2.2 Nitrogen-Containing Fertilizers -- 2.2.1 Economic Importance -- 2.2.1.1 General Information -- 2.2.1.2 Importance of Ammonium Sulfate -- 2.2.1.3 Importance of Ammonium Nitrate -- 2.2.1.4 Importance of Urea -- 2.2.2 Manufacture of Nitrogen-Containing Fertilizers -- 2.2.2.1 Ammonium Sulfate -- 2.2.2.2 Ammonium Nitrate -- 2.2.2.3 Urea -- 2.3 Potassium-Containing Fertilizers -- 2.3.1 Occurrence of Potassium Salts -- 2.3.2 Economic Importance of Potassium-Containing Fertilizers -- 2.3.3 Manufacture of Potassium-Containing Fertilizers -- 2.3.3.1 Potassium Chloride -- 2.3.3.2 Potassium Sulfate -- 2.3.3.3 Potassium Nitrate -- References for Chapter 2: Mineral Fertilizers -- 3 Metals and their Compounds -- 3.1 Alkali and Alkaline Earth Metals and their Compounds -- 3.1.1 Alkali Metals and their Compounds -- 3.1.1.1 General Information -- 3.1.1.2 Lithium and its Compounds -- 3.1.1.2.1 Natural Deposits and Economic Importance -- 3.1.1.2.2 Metallic Lithium -- 3.1.1.2.3 Lithium Compounds -- 3.1.1.3 Sodium and its Compounds -- 3.1.1.3.1 General Information -- 3.1.1.3.2 Metallic Sodium -- 3.1.1.3.3 Sodium Carbonate -- 3.1.1.3.4 Sodium Hydrogen Carbonate -- 3.1.1.3.5 Sodium Sulfate -- 3.1.1.3.6 Sodium Hydrogen Sulfate. , 3.1.1.3.7 Sodium Borates.

Note: Cover -- Handbook of Pediatric Transfusion Medicine -- Copyright -- Dedication -- Table of Contents -- Preface -- Acknowledgments -- About the Editors -- List of Contributors -- Chapter 1 Blood Donation -- Overview -- Donor Recruitment -- Autologous Donation -- Directed Donation -- Limited Donor Exposure -- Blood Collection -- Apheresis -- Plasmapheresis -- References -- Chapter 2 Component Preparation and Storage -- Introduction -- Unique Transfusion Needs of the Neonatal and Pediatric Patient -- Blood Donation Issues -- Anticoagulant-Preservative Solutions -- Individual Components for Transfusion -- Record Keeping for Component Preparation -- Storage of Blood and Blood Products -- Summary -- References -- Chapter 3 Blood Components -- Introduction -- Whole Blood and Packed Red Blood Cells -- Platelets -- Granulocytes -- Plasma Products -- Cryoprecipitate -- Ordering -- Coagulation Factors -- Albumin -- Gamma-Globulins -- References -- Chapter 4 Red Blood Cell Antigens and Human Blood Groups -- Introduction -- ABO Blood Group System -- RH Blood Group System -- Kell Blood Group System -- Duffy Blood Group System -- Clinical Significance -- Kidd Blood Group System -- MNS Blood Group System -- P Blood Group System -- Lutheran Blood Group System -- Lewis Blood Group System -- Diego Blood Group System -- Cartwright Blood Group System -- Xg Blood Group System -- Scianna Blood Group System -- Dombrock Blood Group System -- Colton Blood Group -- LW Blood Group System -- Chido-Rogers Blood Group System -- Hh Blood Group System -- XK Blood Group System -- Gerbich Blood Group System -- Cromer Blood Group System -- Knops Blood Group System -- Indian Blood Group System -- Ok Blood Group System -- RAPH Blood Group System -- JMH Blood Group System -- Cost Blood Group Collection -- Er Blood Group Collection -- Ii Blood Group Collection -- Globoside Collection. , Low-Prevalence Antigens -- High-Prevalence Antigens -- References -- Chapter 5 Pretransfusion Compatibility Testing -- Introduction -- ABO(H) -- Rh(D) -- Other Red Cell Antigens -- Direct Antiglobulin Test -- Antibody Detection Test (Screen) -- Crossmatch (XM) -- Turnaround Times -- Suggested Reading -- References -- Chapter 6 Serologic Investigation of Unexpected Antibodies -- Introduction -- Common Antibody Identification Methods -- Process for Evaluation of Positive Antibody Detection Tests -- References -- Chapter 7 Leukoreduced Products: Prevention of Leukocyte-Related Transfusion-Associated Adverse Effects -- Introduction -- Rationale for Leukoreduction of Blood Components -- Specific Indications for LR Products -- Contraindications, Side Effects, and Hazards -- Leukoreduction Technologies -- Products, Standards, and Quality Control -- Universal Leukoreduction -- Leukoreduced Blood Products and Pediatric Transfusion Medicine -- References -- Chapter 8 Preparation of Blood Components to Reduce Cytomegalovirus and Other Infectious Risks -- Introduction -- Red Blood Cell and Platelet Components with Reduced Infectious Risks -- Plasma Components, Derivatives, and Factors to Eliminate Pathogens -- Nucleic Acid Targeted Inactivation Strategies -- Summary -- References -- Chapter 9 Irradiated Products -- History -- Pathogenesis -- Clinical Manifestations -- Diagnosis of TA-GVHD -- Time Course of Microchimerism -- Groups at Risk -- The Irradiation Process -- Instrumentation for Irradiation -- Components to be Irradiated -- Storage of Red Cells and Platelets after Irradiation -- Selection of Radiation Dose -- Quality Assurance Measures -- Confrming That Irradiation Occurred -- New Methods in the Prevention of TA-GVHD -- Treatment of TA-GVHD -- References -- Chapter 10 Washed and/or Volume- Reduced Blood Components -- Introduction. , Washed Red Blood Cells -- Washed And Volume-Reduced Platelet Concentrates -- References -- Chapter 11 Technical Considerations/Mechanical Devices -- Introduction -- Intravenous Delivery Systems for Blood and Components -- Exchange Transfusion in the Newborn -- References -- Chapter 12 Red Blood Cell Transfusions in the Neonate, Infant, Child, and Adolescent -- Introduction -- RBC Transfusions for Children and Adolescents -- RBC Transfusions for Neonates and Infants -- References -- Chapter 13 Transfusion of the Pediatric Surgery, Trauma, and Intensive Care Unit Patient -- Abstract -- Age, Size, and Rate of Transfusion -- Red Blood Cell Transfusion -- Platelet Transfusions -- Cryoprecipitate and Fresh Frozen Plasma -- Hemostatic Agents in Acute Care -- References -- Chapter 14 Pediatric Transfusion in Developing Countries -- Introduction -- Special Transfusion Issues in Resource-Restricted Countries -- Blood Collection and Processing in Developing Countries -- Risks of Infectious Disease Transmission by Transfusion -- Current Transfusion Practices -- Prevention Measures to Reduce Need for Transfusion -- References -- Chapter 15 Exchange Transfusion in the Infant -- Introduction -- Rationale and Indications -- Procedure -- Selection of Donor Blood -- Complications -- References -- Chapter 16 Granulocyte Transfusions in the Neonate and Child -- Abstract -- Introduction -- Myelopoiesis -- Neonatal Neutropenia and Dysfunction -- Childhood Neutropenia -- Mobilization of Donor Granulocytes -- Therapeutic Granulocyte Transfusions in Children and Adults -- Granulocyte Transfusion in the Neonate -- Summary and Recommendations of Granulocyte Transfusions -- References -- Chapter 17 Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass -- Introduction -- Circuit for ECMO and CPB -- ECMO -- CPB -- Summary -- References. , Chapter 18 Hemolytic Disease of the Newborn -- Introduction -- Immune-Mediated Hemolytic Disease -- Rh Hemolytic Disease -- ABO Hemolytic Disease -- Hemolytic Disease Due to Other Red Cell Antibodies -- T Activation -- Autoimmune Hemolytic Disease -- Red Cell Enzyme Deficiencies -- Red Cell Membrane Defects -- Disorders of Hemoglobin Synthesis -- Other Causes of Hemolytic Disease in Neonates -- Therapy -- References -- Chapter 19 Hemoglobinopathies -- Introduction -- Sickle Cell Disease -- Thalassemias -- References -- Chapter 20 The Bleeding Child: Congenital and Acquired Disorders -- Abstract -- Introduction -- Coagulation Overview -- Clinical Evaluation of Bleeding Problems -- Laboratory Evaluation -- Specific Factor Assays -- Inherited Coagulation Disorders -- Acquired Hemorrhagic Disorders -- References -- Chapter 21 Transfusion of the Patient with Autoimmune Hemolysis -- Introduction -- Clinical Presentation and Laboratory Findings -- Classification -- Warm Autoimmune Hemolytic Anemia -- Cold Agglutinin Syndrome -- Mixed-Type Autoimmune Hemolytic Anemia -- Drug-Induced Hemolytic Anemia -- Less Common Types of Autoimmune Hemolytic Anemia -- Transfusion Therapy in Autoimmune Hemolytic Anemia -- References -- Chapter 22 Platelet Transfusions in the Infant and Child -- Introduction -- Platelet Products and Special Preparations -- Platelet Transfusions in Children -- Platelet Transfusions in Neonates -- Reactions to Platelet Transfusions -- Potential Alternatives to Platelet Transfusions -- References -- Chapter 23 Bone Marrow-Derived Stem Cells -- Introduction -- Product Description -- Collection and Storage -- Special Preparation and Processing -- Expected Response -- Alternative HPC Sources -- References -- Chapter 24 Peripheral Blood Stem Cells -- Introduction -- Product Description -- Collection -- Special Preparation. , Ordering and Administration -- Potential Adverse Effects -- Alternative HPC Sources -- References -- Chapter 25 Umbilical Cord Blood Stem Cells -- Introduction -- Collection, Storage, and Handling -- Clinical Applications -- References -- Chapter 26 Transfusion Reactions -- Introduction -- Acute Hemolytic Transfusion Reactions -- Febrile Nonhemolytic Transfusion Reactions -- Allergic Transfusion Reactions -- Delayed Hemolytic Transfusion Reactions -- Special Considerations for Newborn Infants -- References -- Chapter 27 Noninfectious Complications of Pediatric Transfusion -- Introduction -- Transfusion Reactions -- Metabolic Complications -- Cardiac Overload -- Alloimmunization -- T Antigen Activation -- Dilutional Coagulopathy -- Complications of Iron Overload from Chronic Transfusion -- References -- Chapter 28 Infectious Complications -- Introduction -- Human Immunodeficiency Virus -- Hepatitis -- Human T-Cell Lymphotropic Virus (HTLV) -- Cytomegalovirus -- Parvovirus B19 -- Parasitic Infections -- Creutzfeldt-Jakob Disease -- Bacterial Infections -- References -- Chapter 29 Therapeutic Apheresis -- Introduction -- Goals of Therapeutic Apheresis -- Indication Categories -- Physiology and Adverse Effects -- General Approach to Pediatric Patients Needing Therapeutic Apheresis -- Planning Pediatric Procedures -- Vascular Access -- Hemodynamic Challenges -- Procedural Modifications for Pediatric Patients -- Summary -- Suggested Reading -- Chapter 30 Therapeutic Cytapheresis -- Introduction -- Evidence-Based Practice Guidelines -- General Technical Considerations for Pediatrics -- Erythrocytapheresis/Red Cell Exchange Transfusion -- Leukapheresis -- Plateletpheresis (Thrombocytapheresis) -- Adverse Reactions -- References -- Chapter 31 Therapeutic Plasma Exchange: Rationales and Indications -- Introduction -- Guillain-Barré Syndrome. , Chronic Inflammatory Demyelinating Polyneuropathy.

Note: Front Cover -- Plastics Additives: an Industrial Guide, Volume II -- Copyright Page -- Contents and Subject Index -- SECTION X: IMPACT MODIFIERS -- Atofina Chemicals Inc. -- Mitsubishi Rayon America Inc. -- Roh mand Haas Co. -- SECTION XI: INITIATORS -- Aztec Peroxides, Inc: Laporte, Pic: -- Sartomer Co. -- Witco Corp. -- SECTION XII: LUBRICANTS -- Acme-Hardesty Co. -- Axel Plastics Research Laboratories, Inc. -- Chemax, Inc. -- Lonza Inc. -- Morton Plastics Additives -- Penreco -- Witco Corp. -- SECTION XIII: MICAS -- Franklin Industrial Minerals -- Harwick Standard Distribution Corp. -- Intercorp Inc. -- Pacer Technology, Inc. -- SECTION XIV: PIGMENTS, COLORANTS, AND DYES -- Akzo Nobel -- BASF Corp. -- Cabot Corp. -- Clariant Corp. -- Day-Glo Color Corp. -- Degussa Corp. -- D. J. Enterprises, Inc. -- Eckart America -- EM Industries, Inc. -- Engelhard Corp. -- Heucoteeh Ltd. -- Ishihara Sangyo Kaisha, Ltd -- Kemira Pigments, Inc. -- Kerr-McGee Chemical Corp. -- Kronos Inc. -- Millenium Inorganic Chemicals -- Sun Chemical Corp. -- SECTION XV: PLASTICIZERS AND ESTERS -- Akcros Chemicals -- BP Amoco Chemicals -- Aristech Chemical Corp. -- Arizona Chemical Co. -- BASF Corp. -- ExxonMobil Chemical Co. -- Harwick Standard Distribution Corp. -- Inspec UK Ltd. -- CK Witco Corp. -- Morflex,Inc -- BFGoodrich Kalama, Inc. -- Hatco -- Inolex Chemical Co. -- Rit-Chem Co., Inc. -- Solutia, Inc -- Harwick Standard Distribution Corp.: Dover Chemical Corp -- Unitex Chemical Corp. -- Witco Gorp. -- SECTION XVI: PROCESSING AIDS -- BYK-Chemie, USA -- Croda Oleochemicals -- Dow Chemical Co. -- Dow Corning -- Dyneon LLC -- Eeonyx Corp -- Elm GroveIndustries, Inc. -- Lonza Group -- Mitsubishi Rayon Co., Ltd -- Tego Chemie Service GmbH -- Witco Corp. -- SECTION XVII: RELEASE AGENTS -- Axel Plastics Research Laboratories Inc. -- Slide Products, Inc. -- Stoner Inc. , Witco Corp. -- SECTION XVIII: SILANES, TITANATES AND ZIRCONATES -- Genessee Polymers Corp. -- Kenrich Petrochemicals, Inc. -- SECTION XIX: SLIP AND ANTI-BLOCKING AGENTS -- Akzo Nobel Chemicals Inc. -- Chemax, Inc. -- Degussa AG -- Luzenac America, Inc. -- Witco Corp. -- TRADE NAME INDEX -- SUPPLIERS' ADDRESSES.

Note: Front Cover -- Inside Cover -- Copyright ©2005 Eurekah.com -- CONTENTS -- CONTRIBUTORS -- PREFACE -- ABBREVIATIONS -- Acknowledgements -- CHAPTER 1 Normal Hematopoietic Cell Differentiation -- CHAPTER 2 Application of Monoclonal Antibodies to the Diagnosis and Classification of Acute Leukemias -- CHAPTER 3 Immunophenotypic Markers in the Diagnosis of Non-Hodgkin's Lymphomas -- CHAPTER 4 Clinical Application of Immunophenotyping in Immunodeficiencies -- CHAPTER 5 Immunophenotyping in Hematopoietic Stem Cell Transplantation -- INDEX -- Back Cover.

Note: Front Cover -- Contents -- List of contributors -- Preface -- 1. The Monte Carlo method: theory and computational issues -- 2. Monte Carlo techniques in nuclear medicine dosimetry -- 3. Medical imaging techniques for radiation dosimetry -- 4. Computational methods in internal radiation dosimetry -- 5. Mathematical models of the human anatomy -- 6. Monte Carlo codes for use in therapeutic nuclear medicine -- 7. Dose point-kernels for radionuclide dosimetry -- 8. Radiobiology aspects and radionuclide selection criteria in cancer therapy -- 9. Microdosimetry of targeted radionuclides -- 10. The MABDOSE program for internal radionuclide dosimetry -- 11. The three-dimensional internal dosimetry software package, 3D-ID -- 12. Evaluation and validation of dose calculation procedures in patient-specific radionuclide therapy -- 13. Monte Carlo methods and mathematical models for the dosimetry of skeleton and bone marrow -- 14. Monte Carlo modelling of dose distributions in intravascular radiation therapy -- 15. The Monte Carlo method as a design tool in boron neutron capture synovectomy -- 16. Summary -- Biosketches -- Back Cover.